Could oral fluid be used to evaluate anti-hepatitis A virus status in individuals living in difficult-to-access areas?

Vaccine

Volumn 30, Issue 45, 2012, Pages 6421-6426

  Tourinho, Renata Santos ^a   de Almeida, Adilson José ^a   Amado, Luciane Almeida ^a   Villar, Livia Melo ^a   Castro, Ana Rita Coimbra Motta ^b   de Paula, Vanessa Salete ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

Author keywords

Hepatitis A; Oral fluid; Vaccination

Indexed keywords

HEPATITIS A ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; DEVELOPING COUNTRY; FOLLOW UP; HEPATITIS A VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNOBLOTTING; MEDICAL DEVICE; MONITORING; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; VACCINATION; VEIN PUNCTURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; SALIVA; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; YOUNG ADULT;

EID: 84866522023     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.08.015     Document Type: Article

References (28)

1. Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine 2000, 18:57-60.
2. Vitral C.L., Gaspar A.M.C., Souto F.J.D. Epidemiological pattern and mortality rates for hepatitis A in Brazil: 1980-2002 - a review. Mem Inst Oswaldo Cruz 2006, 101(2):119-127.
3. Arankalle V.A., Chadha M.S. Who should receive hepatitis A vaccine. J Viral Hepat 2003, 10(May):157-158.
4. Vitral C.L., Yoshida C.F.T., Lemos E.R., Teixeira C.S., Gaspar A.M.C. Age-specific prevalence of antibodies to hepatitis A in children and adolescents from Rio de Janeiro, Brazil, 1978 and 1995. Relationship of prevalence to environmental factors. Mem Inst Oswaldo Cruz 1998, 93:1-5.
5. De Cock L., Hutse V., Verhaegen E., Quoilin S., Vandenberghe H., Vranckx R. Detection of HCV antibodies in oral fluid. J Virol Methods 2004, 122:179-183.
6. Parry J.V. Detection of viral antibodies in saliva specimens as an alternative to serum. J Clin Chem Clin Biochem 1989, 27:245-246.
7. Ochnio J.J., Scheifele D.H., Ho M., Mitchell L.A. New, ultrasensitive enzyme immunoassay for detecting vaccine and disease-induced hepatitis A virus-specific immunoglobulin G in saliva. J Clin Microbiol 1997, 35(1):98-101.
8. Oba I.T., Spina A.M.M., Saraceni C.P., Lemos M.F., Senhoras R.C.F.A., Moreira R.C., et al. Detection of hepatitis A antibodies by ELISA using saliva as clinical samples. Rev Inst Med Trop São Paulo 2000, 42(4):197-200.
9. Morris-Cunnington M.C., Edmunds W.J., Miller E., Brown D.W.G. A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales. Am J Epidemiol 2004, 159:786-794.
10. Amado L.A., Villar L.M., De Paula V.S., De Almeida A.J., Gaspar A.M.C. Detection of hepatitis A, B and C virus-specific antibodies using oral fluid for epidemiological studies. Mem Inst Oswaldo Cruz 2006, 101:149-155.
11. Zaaijer H.L., Leentwaar-Kuijpers A., Rotman H., Lelie P.N. Hepatitis A antibody titers after infection and immunization: implication for passive and active immunization. J Med Virol 1993, 40:22-27.
12. Challacombe S.J., Russell M.W., Hawkes J. Passage of intact IgG from plasma to the oral cavity via crevicular fluid. Clin Exp Immunol 1978, 34(3):417-422.
13. Roitt I., Lehner T. Oral immunity of oral disease 1983, Oxford, Blackwell, p. 279-304. 2nd ed.
14. Parry J.V. Simple and reliable salivary test for HIV and hepatitis A and B virus diagnosis and surveillance. Ann N Y Acad Sci 1993, 694:216-233.
15. Nokes D.J., Enquselassie F., Vyse A., Nigatu W., Cutts F.T., Brown D.W. An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community. Trans R Soc Trop Med Hyg 1998, 92(November-December (6)):679-685.
16. Altman D.G. Practical statistics for medical research 1991, Chapman and Hall/CRC, London, p. 611.
17. Stark K., Warnecke C., Brinkmann V., Gelderblom H.R., Bienzle U., Pauli G. Sensitivity of HIV antibody detection in saliva. Med Microbiol Immunol (Berl) 1993, 182(3):147-151.
18. Advisory Committee on Immunization Practices (ACIP), Fiore A.E., Wasley A., Bell B.P. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 19(May (55) (RR-7)):1-23.
19. Centers for Disease Control Prevention (CDC) Hepatitis A vaccination coverage among U.S. children aged 12-23 months - immunization information system sentinel sites, 2006-2009. MMWR Morb Mortal Wkly Rep 2010, 59(July (25)):776-779.
20. McIntyre P.G., Laszlo J., Appleyard K., Ogden G.R. Modified enzyme immunoassay to detect hepatitis C virus antibodies in oral fluid. Eur J Microbiol Infect Dis 1996, 15:882-884.
21. Judd A., Parry J., Hickman M., McDonald T., Jordan L., Lewis K., et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003, 71:49-55.
22. Tourinho R.S., Amado L.A., Villar L.M., Sampaio D.V., Moraes A.C., Rodrigues do Ó.K.M., et al. Importance of the cutoff ratio for detecting antibodies against hepatitis A virus in oral fluids by enzyme immunoassay. J Virol Methods 2011, 173:169-174.
23. Quoilin S., Hutse V., Vandenberghe H., Claeys F., Verhaegen E., De Cock L., et al. A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium. Eur J Epidemiol 2007, 22(3):195-202.
24. Chang C.K., Cohen M.E., Bienek D.R. Efficiency of oral fluid collection devices in extracting antibodies. Oral Microbiol Immunol 2009, 24(3):231-235.
25. van den Akker R., van den Hoek J.A., van den Akker W.M., Kooy H., Vijge E., Roosendaal G., et al. Detection of HIV antibodies in saliva as a tool for epidemiological studies. AIDS 1992, 6(September (9)):953-957.
26. Gröschl M., Köhler H., Topf H.G., Rupprecht T., Rauh M. Evaluation of saliva collection devices for the analysis of steroids, peptides and therapeutic drugs. J Pharm Biomed Anal 2008, 47(July (3)):478-486.
27. Vyse A.J., Chen B.J., Ramsay M.E. A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children. Public Health 2001, 115:201-207.
28. Nokes D.J., Enquselassie F., Nigatu W., Vyse A.J., Cohen B.J., Brown D.W., et al. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organ 2001, 79(7):588.